Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NeuroPace (NPCE) Capital Expenditures (2020 - 2025)

NeuroPace (NPCE) has 6 years of Capital Expenditures data on record, last reported at $97000.0 in Q4 2025.

  • For Q4 2025, Capital Expenditures rose 148.72% year-over-year to $97000.0; the TTM value through Dec 2025 reached $332000.0, up 8.5%, while the annual FY2025 figure was $332000.0, 8.5% up from the prior year.
  • Capital Expenditures reached $97000.0 in Q4 2025 per NPCE's latest filing, down from $210000.0 in the prior quarter.
  • Across five years, Capital Expenditures topped out at $306000.0 in Q1 2022 and bottomed at -$377000.0 in Q4 2022.
  • Average Capital Expenditures over 5 years is $69421.1, with a median of $39000.0 recorded in 2024.
  • Peak YoY movement for Capital Expenditures: tumbled 231.36% in 2022, then soared 2866.67% in 2024.
  • A 5-year view of Capital Expenditures shows it stood at $287000.0 in 2021, then crashed by 231.36% to -$377000.0 in 2022, then skyrocketed by 108.49% to $32000.0 in 2023, then grew by 21.88% to $39000.0 in 2024, then surged by 148.72% to $97000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Capital Expenditures were $97000.0 in Q4 2025, $210000.0 in Q3 2025, and -$12000.0 in Q2 2025.